NO175856C - Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer - Google Patents

Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer

Info

Publication number
NO175856C
NO175856C NO911419A NO911419A NO175856C NO 175856 C NO175856 C NO 175856C NO 911419 A NO911419 A NO 911419A NO 911419 A NO911419 A NO 911419A NO 175856 C NO175856 C NO 175856C
Authority
NO
Norway
Prior art keywords
alpha
novel
preparation
analogous process
fucosidase inhibitors
Prior art date
Application number
NO911419A
Other languages
English (en)
Norwegian (no)
Other versions
NO911419L (no
NO911419D0 (no
NO175856B (es
Inventor
Robert A Farr
Norton P Peet
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO911419D0 publication Critical patent/NO911419D0/no
Publication of NO911419L publication Critical patent/NO911419L/no
Publication of NO175856B publication Critical patent/NO175856B/no
Publication of NO175856C publication Critical patent/NO175856C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
NO911419A 1990-04-12 1991-04-11 Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer NO175856C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (4)

Publication Number Publication Date
NO911419D0 NO911419D0 (no) 1991-04-11
NO911419L NO911419L (no) 1991-10-14
NO175856B NO175856B (es) 1994-09-12
NO175856C true NO175856C (no) 1994-12-21

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
NO911419A NO175856C (no) 1990-04-12 1991-04-11 Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer

Country Status (19)

Country Link
EP (1) EP0451834B1 (es)
JP (1) JP2955057B2 (es)
KR (1) KR100197382B1 (es)
CN (1) CN1033638C (es)
AT (1) ATE140692T1 (es)
AU (1) AU646855B2 (es)
CA (1) CA2040058C (es)
DE (1) DE69121000T2 (es)
DK (1) DK0451834T3 (es)
ES (1) ES2092520T3 (es)
FI (1) FI109200B (es)
GR (1) GR3020934T3 (es)
HU (1) HU213396B (es)
IE (1) IE75195B1 (es)
IL (1) IL97814A (es)
NO (1) NO175856C (es)
NZ (1) NZ237734A (es)
PT (1) PT97339B (es)
ZA (1) ZA912588B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
AU736668B2 (en) * 1996-10-01 2001-08-02 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts
JP6170675B2 (ja) * 2010-01-28 2017-07-26 ラプトール ファーマシューティカルズ インコーポレイテッド 受容体関連タンパク質（ｒａｐ）ペプチド−フコシダーゼ阻害薬複合体による肝障害処置のための方法
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
AU646855B2 (en) 1994-03-10
CN1055732A (zh) 1991-10-30
EP0451834A2 (en) 1991-10-16
FI911751A (fi) 1991-10-13
HUT60994A (en) 1992-11-30
ZA912588B (en) 1992-01-29
DE69121000T2 (de) 1996-12-19
EP0451834B1 (en) 1996-07-24
NO911419L (no) 1991-10-14
IL97814A0 (en) 1992-06-21
HU911196D0 (en) 1991-10-28
IE911229A1 (en) 1991-10-23
ATE140692T1 (de) 1996-08-15
ES2092520T3 (es) 1996-12-01
GR3020934T3 (en) 1996-12-31
NZ237734A (en) 1993-05-26
FI911751A0 (fi) 1991-04-11
PT97339B (pt) 1998-08-31
HU213396B (en) 1997-06-30
CA2040058A1 (en) 1991-10-13
IL97814A (en) 1995-08-31
NO911419D0 (no) 1991-04-11
JPH04234834A (ja) 1992-08-24
IE75195B1 (en) 1997-08-27
CN1033638C (zh) 1996-12-25
DK0451834T3 (da) 1996-08-26
AU7416491A (en) 1991-10-17
FI109200B (fi) 2002-06-14
PT97339A (pt) 1992-01-31
KR100197382B1 (ko) 1999-06-15
KR910018341A (ko) 1991-11-30
JP2955057B2 (ja) 1999-10-04
NO175856B (es) 1994-09-12
DE69121000D1 (de) 1996-08-29
CA2040058C (en) 2001-10-23
EP0451834A3 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
ATE269290T1 (de) Benzoylderivate
BG41130A3 (en) Method for preparing 8- chlor-1, 5- benzo- thiazepine derivatives
FI904734A0 (fi) Anordning foer maetning av tryckdifferens.
FI880429A0 (fi) Foerfarande foer utbredning av ett eldfast skikt med hjaelp av sprutning pao en yta och ett pao detta saett bildat skikt.
NO175856C (no) Analogifremgangsmåte for fremstilling av nye - og fucosidase-inhibitorer
AR246162A1 (es) Composicion antimicrobiana
IT1211125B (it) Composti azotati. processo per la preparazione di
NO951163D0 (no) Metode for antagonisering av inositol-1,4,5-trifosfat
NO176098C (no) Analogifremgangsmåte for fremstilling av 2-substituerte N,N'-ditrimetoksybenzoyl-piperaziner
ITMI910320A1 (it) Processo per la preaparazione di 1. 3-diossoli
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
IT8720360A0 (it) Metodo per prevenire l'appannamento di superfici.
FI901245A0 (fi) Foerfarande foer framstaellning av en relieftryckplatta med en klibbfri tryckande yta.
NO873353D0 (no) Fremgangsmaate for fremstilling av antibakterielle 7-okso-4-tia-1-azabicyklo(3.2.0)hept-2-en-derivater.
ITMI912560A0 (it) Processo per la preparazioned di 2-ammino-5,6 dimetossi-tetralina
IT8848548A0 (it) Procedimento per il post-trattamento di substrati tinti, stampati o foulardati
IT8120307A0 (it) Disposizione per il trattamento termico di pezzi d'opera.
BG43004A3 (en) Method for preparing condensed as- triazines
NO922545D0 (no) Fremgangsmaate for fremstilling av 1beta-ethyl-1alfa(hydroxymethyl)-1,2,3,4,6,7,12alfa-octahydro-indolo(2,3-a)kinolizinog nye mellomprodukter
BR1100243A (pt) Derivados do ácido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0.3,8) undec-2-eno-2-carboxìlico
IT8921649A0 (it) Processo per la riduzione catalistica di composti carbonilici.
IT8882502A0 (it) Apparecchiatura per la decorazione particolarmente di ceramiche.
ES542481A0 (es) Procedimiento para la sintesis de la 2,4-bis(alilamino)-6-(4-(bis-(p-fluorofenil)metil))-1-piperazin-il)-s-triazina
FI862875A0 (fi) Foerfarande och anlaeggning foer gjutning av betongprodukter i kontinuerling process med straenggjutningsmaskin.
AR241135A2 (es) "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene".